Document is current
Any future updates will be listed below
-
Authors
Wheeler, Emily C.
Vu, Anthony Q. https://orcid.org/0000-0001-8922-6409
Einstein, Jaclyn M.
DiSalvo, Matthew
Ahmed, Noorsher https://orcid.org/0000-0003-1701-3994
Van Nostrand, Eric L.
Shishkin, Alexander A.
Jin, Wenhao
Allbritton, Nancy L.
Yeo, Gene W.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HG004659, EY024556)
National Science Foundation (GRFP, GRFP)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (K99HG009530)
- License Information
-
More Information
Article History
Received: 30 October 2019
Accepted: 6 April 2020
First Online: 11 May 2020
Competing interests
: G.W.Y. is co-founder, member of the Board of Directors, on the SAB, equity holder and paid consultant for Locana and Eclipse BioInnovations. G.W.Y is a visiting professor at the National University of Singapore. E.L.V. is co-founder, member of the Board of Directors, on the SAB, equity holder and paid consultant for Eclipse BioInnovations. The interests of G.W.Y. and E.L.V. have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. N.L.A. is a co-founder, on the SAB, equity holder and paid consultant for Altis Biosystems and a co-founder and equity holder in Cell Microsystems. The interests of N.L.A. have been reviewed and approved by the University of North Carolina, Chapel Hill through 1 November 2019 and by University of Washington, Seattle as of 1 November 2019 in accordance with their conflict of interest policies. The authors declare no other competing interests.
